See more : Renergetica S.p.A. (REN.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Tilray Brands, Inc. (TLRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tilray Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Zhuzhou CRRC Times Electric Co., Ltd. (ZHUZY) Income Statement Analysis – Financial Results
- Dhampur Sugar Mills Limited (DHAMPURSUG.NS) Income Statement Analysis – Financial Results
- OUTLOOKCONSULTING CO LTD (5596.T) Income Statement Analysis – Financial Results
- Linus Digital Finance AG (LDF.F) Income Statement Analysis – Financial Results
- Avalon Technologies Limited (AVALON.NS) Income Statement Analysis – Financial Results
Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 788.94M | 627.12M | 628.37M | 513.09M | 391.00M | 175.25M | 28.63M | 15.17M | 6.47M | 443.70K | 0.00 | 0.00 |
Cost of Revenue | 565.59M | 480.16M | 511.56M | 389.90M | 253.31M | 119.50M | 3.97M | 2.33M | 1.88M | 567.59K | 0.00 | 0.00 |
Gross Profit | 223.35M | 146.96M | 116.82M | 123.18M | 137.68M | 55.74M | 24.66M | 12.84M | 4.58M | -123.89K | 0.00 | 0.00 |
Gross Profit Ratio | 28.31% | 23.43% | 18.59% | 24.01% | 35.21% | 31.81% | 86.13% | 84.63% | 70.87% | -27.92% | 0.00% | 0.00% |
Research & Development | 635.00K | 682.00K | 1.52M | 830.00K | 1.85M | 1.03M | 380.00K | 365.52K | 168.99K | 55.95K | 0.00 | 0.00 |
General & Administrative | 171.56M | 165.16M | 162.80M | 111.58M | 88.30M | 70.83M | 24.64M | 5.25M | 2.21M | 5.33M | 45.34K | 98.51K |
Selling & Marketing | 79.17M | 65.78M | 65.86M | 44.12M | 29.92M | 20.67M | 9.21M | 4.95M | 2.76M | 579.52K | 0.00 | 0.00 |
SG&A | 250.72M | 230.94M | 228.66M | 155.69M | 118.22M | 91.50M | 33.85M | 10.20M | 4.97M | 5.91M | 45.34K | 98.51K |
Other Expenses | 146.74M | -66.91M | 115.19M | 35.22M | 15.68M | 10.41M | 1.98M | 379.96K | 277.37K | -3.28M | 0.00 | 0.00 |
Operating Expenses | 398.10M | 325.11M | 345.37M | 191.74M | 135.75M | 102.94M | 37.32M | 11.28M | 5.42M | 6.01M | 45.34K | 98.51K |
Cost & Expenses | 963.69M | 805.27M | 856.93M | 581.64M | 389.07M | 222.44M | 34.24M | 13.61M | 7.30M | 5.81M | 45.34K | 98.51K |
Interest Income | 12.83M | 33.03M | 11.74M | 2.93M | 5.79M | 10.61M | 4.93M | 827.91K | 215.83K | 104.79K | 3.35K | 2.08K |
Interest Expense | 49.26M | 13.59M | 39.68M | 30.90M | 24.78M | 5.75M | 1.05M | 287.34K | 215.83K | 104.79K | 3.35K | 2.08K |
Depreciation & Amortization | 126.91M | 130.15M | 115.19M | 35.22M | 15.68M | 16.95M | 5.18M | 1.44M | 730.05K | 306.47K | 0.00 | 0.00 |
EBITDA | -72.84M | -889.52M | -246.40M | -218.36M | -18.40M | -36.66M | -658.00K | 4.37M | 115.11K | -5.06M | -1.43M | -608.47K |
EBITDA Ratio | -9.23% | -18.32% | 42.73% | 5.90% | 17.18% | 8.19% | -2.55% | 28.80% | -1.73% | -1,141.18% | 0.00% | 0.00% |
Operating Income | -174.75M | -1.37B | 153.30M | -4.95M | 51.48M | -2.60M | -9.64M | -1.03M | -836.23K | -2.73M | -45.34K | -98.51K |
Operating Income Ratio | -22.15% | -218.41% | 24.40% | -0.96% | 13.17% | -1.48% | -33.66% | -6.81% | -12.93% | -615.78% | 0.00% | 0.00% |
Total Other Income/Expenses | -74.28M | -80.50M | 169.73M | -212.82M | -5.18M | 100.79M | 40.23M | 151.61K | 221.29K | -2.53M | 0.00 | 2.08K |
Income Before Tax | -249.02M | -1.45B | -440.67M | -344.99M | -58.19M | -11.56M | 27.81M | 3.22M | -614.94K | -5.27M | -41.99K | -96.43K |
Income Before Tax Ratio | -31.56% | -231.24% | -70.13% | -67.24% | -14.88% | -6.60% | 97.13% | 21.20% | -9.51% | -1,186.63% | 0.00% | 0.00% |
Income Tax Expense | -26.62M | -7.18M | -6.54M | -8.97M | 2.82M | 631.19K | 4.97M | 99.29K | -920.06K | -3.38M | 0.00 | 0.00 |
Net Income | -244.98M | -1.44B | -434.13M | -336.01M | -61.02M | -12.19M | 22.84M | 3.12M | 305.12K | -5.27M | -41.99K | -96.43K |
Net Income Ratio | -31.05% | -230.10% | -69.09% | -65.49% | -15.61% | -6.96% | 79.77% | 20.54% | 4.72% | -1,186.63% | 0.00% | 0.00% |
EPS | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.17 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
EPS Diluted | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.16 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
Weighted Avg Shares Out | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 134.96M | 87.45M | 48.98M | 38.04M | 3.34M | 2.31M |
Weighted Avg Shares Out (Dil) | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 139.05M | 93.39M | 48.98M | 38.04M | 3.34M | 2.31M |
New Strong Buy Stocks for October 18th
3 Must-Buy Efficient Stocks to Increase Portfolio Returns
Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading Innovation in Brands and Products
Top Marijuana Stocks For Making Gains In The Sector
Is Tilray Brands Stock a Buy?
Tilray: Another Weed In The Garden
Tilray CEO: We're a consumer goods company
Tilray CEO on Cannabis Legalization & 1Q Earnings
Tilray CEO Bullish on Cannabis Legalization Following 2024 Election
Tilray Brands, Inc. (TLRY) Q1 2025 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports